Covered recipient · General Payments record
AYAZ T MADRASWALLA
Allopathic & Osteopathic Physicians Family Medicine Addiction Medicine
General Payments · PY2018–2024
$24,294.61
- Reported across 229 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $323.46 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Indivior Inc. | $76.27 | 3 |
| Lilly USA, LLC | $54.16 | 3 |
| Novo Nordisk AS | $31.08 | 2 |
| ITI, Inc. | $30.41 | 1 |
| Exact Sciences Corporation | $28.37 | 1 |
| Kyowa Kirin, Inc. | $27.34 | 1 |
| ABBVIE INC. | $27.29 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $26.57 | 1 |
| Merck Sharp & Dohme Corporation | $21.97 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.29 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104922908 | CMS |
| Exact Sciences Corporation | $28.37 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114767390 | CMS |
| Indivior Inc. | $21.20 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144532623 | CMS |
| Indivior Inc. | $31.92 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144532625 | CMS |
| Indivior Inc. | $23.15 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144532627 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $30.41 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143268456 | CMS |
| Kyowa Kirin, Inc. | $27.34 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127025980 | CMS |
| Lilly USA, LLC | $21.61 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136003035 | CMS |
| Lilly USA, LLC | $14.15 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136054472 | CMS |
| Lilly USA, LLC | $18.40 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136058590 | CMS |
| Merck Sharp & Dohme LLC | $21.97 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141657560 | CMS |
| Novartis Pharmaceuticals Corporation | $26.57 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087155670 | CMS |
| Novo Nordisk Inc | $15.56 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097575663 | CMS |
| Novo Nordisk Inc | $15.52 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096917864 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.